Comments
Loading...
Sangamo Therapeutics Stock Guidance | NASDAQ:SGMO | Benzinga
Sangamo Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/26/2023 | SGMO | Sangamo Therapeutics | Q1 | 2023 | — | — | — | $158.00M | $158.00M | — | Get Alert |
FAQ
What is the most recent guidance for Sangamo Therapeutics (SGMO)?
There have been no specific sales or earnings guidance reported for Sangamo Therapeutics in recent months.
Browse guidance and forecast on all stocks.
